SANDRA LEE BARKER
Prescription History 1679250484
Nurse Practitioner - Psychiatric/Mental Health in Bel Air, MD

Active since July 03, 2023PECOS EnrolledAccepts Medicare Assignment
426 UNDERWOOD CIR, BEL AIR, MD 21014(410) 375-6502 Get Directions

NPPES record last updated: January 23, 2024. Verified against the NPPES registry weekly; last sync: October 25, 2026.

Medicare Part D Prescription History

Explore the verified Medicare Part D prescription history, volume metrics, and calculated drug costs for SANDRA LEE BARKER, an active Psychiatric/Mental Health specialist practicing in Bel Air, MD. Our medical registry currently tracks 2 unique pharmaceutical formulations prescribed by this provider, representing an estimated volume of 31 documented patient claims. Among these therapy options, the most frequently utilized medication is Quetiapine Fumarate, which accounts for 18 claims alone. Use the table below to sort by claims, cost, or utilization compared with the state average; select any medication for its full profile.

2
Medications
31
Total Claims
31
30-Day Fills
Quetiapine Fumarate
Most Prescribed · 18 claims
View details
2 medications · 2024 Medicare Part D
Medicare Part D medications prescribed by SANDRA LEE BARKER in 2024, with prescription volumes, average cost per fill, and MD state comparisons
Medication Prescriptions (2024)Rx (2024) Avg Cost per FillCost / Fill Vs. Other MD PrescribersVs. MD Avg
Quetiapine Fumarate18$15.76▼ below MD avg▼ Less than typical

About Quetiapine Fumarate: This medication is used to treat certain mental/mood disorders (such as schizophrenia, bipolar disorder, sudden episodes of mania or depression associated with bipolar disorder). Show more ▾

Quetiapine belongs to a class of drugs known as atypical antipsychotics. It works by helping to restore the balance of certain natural substances in the brain. A dibenzothiazepine and ANTIPSYCHOTIC AGENT that targets the SEROTONIN 5-HT2 RECEPTOR; HISTAMINE H1 RECEPTOR, adrenergic alpha1 and alpha2 receptors, as well as the DOPAMINE D1 RECEPTOR and DOPAMINE D2 RECEPTOR. It is used in the treatment of SCHIZOPHRENIA; BIPOLAR DISORDER and DEPRESSIVE DISORDER.

In 2024, this provider wrote 18 Medicare prescriptions for Quetiapine Fumarate, about a third of the volume of the typical Maryland prescriber of this medication (52.8). Medicare paid an average of $15.76 per fill, versus $18.24 statewide.

How often this provider prescribes it

This provider
18
MD average
52.8

This provider prescribes this medication less often than the average MD prescriber. Utilization reflects practice size as well as clinical preference.

What Medicare paid per fill

This provider
$15.76
MD average
$18.24

This provider's average cost per fill is below the MD average for this medication.

18.1
30-Day Fills
standardized to 30-day supplies
541
Days of Medication
total across all patients in 2024
Aripiprazole13$63.78▼ below MD avg▼ Less than typical

About Aripiprazole: This medication is used to treat certain mental/mood disorders (such as bipolar disorder, schizophrenia, Tourette's syndrome, and irritability associated with autistic disorder). Show more ▾

It may also be used in combination with other medication to treat depression. Aripiprazole belongs to a class of drugs known as atypical antipsychotics. It works by helping to restore the balance of certain natural substances in the brain. This medication can decrease hallucinations and improve your concentration. It helps you to think more clearly and positively about yourself, feel less nervous, and take a more active part in everyday life. Aripiprazole can treat severe mood swings and decrease how often mood swings occur. A piperazine and quinolone derivative that is used primarily as an antipsychotic agent. It is a partial agonist of SEROTONIN RECEPTOR, 5-HT1A and DOPAMINE D2 RECEPTORS, where it also functions as a post-synaptic antagonist, and an antagonist of SEROTONIN RECEPTOR, 5-HT2A. It is used for the treatment of SCHIZOPHRENIA and BIPOLAR DISORDER, and as an adjunct therapy for the treatment of depression.

In 2024, this provider wrote 13 Medicare prescriptions for Aripiprazole, about a third of the volume of the typical Maryland prescriber of this medication (39.1). Medicare paid an average of $63.78 per fill, versus $71.76 statewide.

How often this provider prescribes it

This provider
13
MD average
39.1

This provider prescribes this medication less often than the average MD prescriber. Utilization reflects practice size as well as clinical preference.

What Medicare paid per fill

This provider
$63.78
MD average
$71.76

This provider's average cost per fill is below the MD average for this medication.

13
30-Day Fills
standardized to 30-day supplies
390
Days of Medication
total across all patients in 2024
No medications match the current filters.
▲ More than typical≈ Typical▼ Less than typical= prescription volume vs the average MD prescriber of the same medication; volume reflects practice size as well as clinical preference.Green cost= below the MD average cost per fill.

About this data. The prescription history for SANDRA LEE BARKER is compiled from the Centers for Medicare & Medicaid Services (CMS) Medicare Part D Prescriber Public Use File for calendar year 2024, the most recent federal release. Figures cover prescriptions filled for Medicare Part D beneficiaries only; prescriptions under private insurance, Medicaid, or self-pay plans are not included. Because prescribing decisions are generally consistent across coverage types, this record offers a useful view of the overall Psychiatric/Mental Health prescribing approach at this Bel Air, MD practice.

Reading the costs. Drug costs are gross amounts paid to pharmacies under Part D, including both plan and beneficiary payments. They are not the price a patient pays at the pharmacy counter. Medications with fewer than 11 claims are excluded from the federal source data, and state comparisons use the average among MD prescribers of the same medication and form, shown only when at least five prescribers contribute. Always confirm current medications and costs directly with the provider and your plan.

About the medication summaries. Drug use descriptions come from the CMS Medicare Part D Drug Spending Dashboard (2024), and substance definitions from Medical Subject Headings (MeSH) 2026, U.S. National Library of Medicine. They are summaries that do not contain all possible information about a medication and are not individual medical advice. Ask a health care professional about any medication and your specific health needs.